Search

Your search keyword '"Bellavita, Giulia"' showing total 21 results
Start Over Author "Bellavita, Giulia"
21 results on '"Bellavita, Giulia"'

3. Correction: Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Author

Bongianni, Matilde, Catalan, Mauro, Perra, Daniela, Fontana, Elena, Janes, Francesco, Bertolotti, Claudio, Sacchetto, Luca, Capaldi, Stefano, Tagliapietra, Matteo, Polverino, Paola, Tommasini, Valentina, Bellavita, Giulia, Kachoie, Elham Ataie, Baruca, Roberto, Bernardini, Andrea, Valente, Mariarosaria, Fiorini, Michele, Bronzato, Erika, Tamburin, Stefano, Bertolasi, Laura, Brozzetti, Lorenzo, Cecchini, Maria Paola, Gigli, Gianluigi, Monaco, Salvatore, Manganotti, Paolo, and Zanusso, Gianluigi

Published
2022
Full Text
View/download PDF

4. Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Author

Bongianni, Matilde, Catalan, Mauro, Perra, Daniela, Fontana, Elena, Janes, Francesco, Bertolotti, Claudio, Sacchetto, Luca, Capaldi, Stefano, Tagliapietra, Matteo, Polverino, Paola, Tommasini, Valentina, Bellavita, Giulia, Kachoie, Elham Ataie, Baruca, Roberto, Bernardini, Andrea, Valente, Mariarosaria, Fiorini, Michele, Bronzato, Erika, Tamburin, Stefano, Bertolasi, Laura, Brozzetti, Lorenzo, Cecchini, Maria Paola, Gigli, Gianluigi, Monaco, Salvatore, Manganotti, Paolo, and Zanusso, Gianluigi

Published
2022
Full Text
View/download PDF

9. Guillain‐Barré syndrome and COVID ‐19: A 1‐year observational multicenter study

Author

Filosto, Massimiliano, primary, Cotti Piccinelli, Stefano, additional, Gazzina, Stefano, additional, Foresti, Camillo, additional, Frigeni, Barbara, additional, Servalli, Maria Cristina, additional, Sessa, Maria, additional, Cosentino, Giuseppe, additional, Marchioni, Enrico, additional, Ravaglia, Sabrina, additional, Briani, Chiara, additional, Castellani, Francesca, additional, Zara, Gabriella, additional, Bianchi, Francesca, additional, Del Carro, Ubaldo, additional, Fazio, Raffaella, additional, Filippi, Massimo, additional, Magni, Eugenio, additional, Natalini, Giuseppe, additional, Palmerini, Francesco, additional, Perotti, Anna Maria, additional, Bellomo, Andrea, additional, Osio, Maurizio, additional, Nascimbene, Caterina, additional, Carpo, Marinella, additional, Rasera, Andrea, additional, Squintani, Giovanna, additional, Doneddu, Pietro Emiliano, additional, Bertasi, Valeria, additional, Cotelli, Maria Sofia, additional, Bertolasi, Laura, additional, Fabrizi, Gian Maria, additional, Ferrari, Sergio, additional, Ranieri, Federico, additional, Caprioli, Francesca, additional, Grappa, Elena, additional, Manganotti, Paolo, additional, Bellavita, Giulia, additional, Furlanis, Giovanni, additional, De Maria, Giovanni, additional, Leggio, Ugo, additional, Poli, Loris, additional, Rasulo, Frank, additional, Latronico, Nicola, additional, Nobile‐Orazio, Eduardo, additional, Beghi, Ettore, additional, Padovani, Alessandro, additional, and Uncini, Antonino, additional

Published
2022
Full Text
View/download PDF

10. Olfactory swab sampling optimization for α-synuclein aggregates detection in patients with Parkinson’s disease

Author

Bongianni, Matilde, primary, Catalan, Mauro, additional, Perra, Daniela, additional, Fontana, Elena, additional, Janes, Francesco, additional, Bertolotti, Claudio, additional, Sacchetto, Luca, additional, Capaldi, Stefano, additional, Tagliapietra, Matteo, additional, Polverino, Paola, additional, Tommasini, Valentina, additional, Bellavita, Giulia, additional, Kachoie, Elham Ataie, additional, Baruca, Roberto, additional, Bernardini, Andrea, additional, Valente, Mariarosaria, additional, Fiorini, Michele, additional, Bronzato, Erika, additional, Tamburin, Stefano, additional, Bertolasi, Laura, additional, Brozzetti, Lorenzo, additional, Cecchini, Maria Paola, additional, Gigli, Gianluigi, additional, Monaco, Salvatore, additional, Manganotti, Paolo, additional, and Zanusso, Gianluigi, additional

Published
2022
Full Text
View/download PDF

11. Additional file 1 of Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Author

Bongianni, Matilde, Catalan, Mauro, Perra, Daniela, Fontana, Elena, Janes, Francesco, Bertolotti, Claudio, Sacchetto, Luca, Capaldi, Stefano, Tagliapietra, Matteo, Polverino, Paola, Tommasini, Valentina, Bellavita, Giulia, Kachoie, Elham Ataie, Baruca, Roberto, Bernardini, Andrea, Valente, Mariarosaria, Fiorini, Michele, Bronzato, Erika, Tamburin, Stefano, Bertolasi, Laura, Brozzetti, Lorenzo, Cecchini, Maria Paola, Gigli, Gianluigi, Monaco, Salvatore, Manganotti, Paolo, and Zanusso, Gianluigi

Abstract

Additional file 1: Fig. S1 Olfactory mucosa (OM) sample without substrate (recombinant α-syn and reaction buffer) (red trace) and substrate without OM (black trace) were tested by RT-QuIC.

Published
2022
Full Text
View/download PDF

15. Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID‐19 neuropathy patients

Author

Manganotti, Paolo, primary, Bellavita, Giulia, additional, Tommasini, Valentina, additional, D′Acunto, Laura, additional, Fabris, Martina, additional, Cecotti, Laura, additional, Furlanis, Giovanni, additional, Sartori, Arianna, additional, Bonzi, Lucia, additional, Buoite Stella, Alex, additional, and Pesavento, Valentina, additional

Published
2021
Full Text
View/download PDF

19. Does the Degree of Trunk Bending Predict Patient Disability, Motor Impairment, Falls, and Back Pain in Parkinson's Disease?

Author

Geroin, Christian, primary, Artusi, Carlo Alberto, additional, Gandolfi, Marialuisa, additional, Zanolin, Elisabetta, additional, Ceravolo, Roberto, additional, Capecci, Marianna, additional, Andrenelli, Elisa, additional, Ceravolo, Maria Gabriella, additional, Bonanni, Laura, additional, Onofrj, Marco, additional, Telese, Roberta, additional, Bellavita, Giulia, additional, Catalan, Mauro, additional, Manganotti, Paolo, additional, Mazzucchi, Sonia, additional, Giannoni, Sara, additional, Vacca, Laura, additional, Stocchi, Fabrizio, additional, Casali, Miriam, additional, Falup-Pecurariu, Cristian, additional, Zibetti, Maurizio, additional, Fasano, Alfonso, additional, Lopiano, Leonardo, additional, and Tinazzi, Michele, additional

Published
2020
Full Text
View/download PDF

20. Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain‐Barré syndrome and polyneuritis cranialis in COVID‐19 patients: A case series.

Author

Manganotti, Paolo, Bellavita, Giulia, D'Acunto, Laura, Tommasini, Valentina, Fabris, Martina, Sartori, Arianna, Bonzi, Lucia, Buoite Stella, Alex, and Pesavento, Valentina

Subjects
GUILLAIN-Barre syndrome, COVID-19, PERIPHERAL nervous system, CEREBROSPINAL fluid examination, COVID-19 pandemic, TASTE disorders, FACIAL nerve diseases
Abstract

We report a case series of five patients affected by SARS‐CoV‐2 who developed neurological symptoms, mainly expressing as polyradiculoneuritis and cranial polyneuritis in the 2 months of COVID‐19 pandemic in a city in the northeast of Italy. A diagnosis of Guillain‐Barré syndrome was made on the basis of clinical presentation, cerebrospinal fluid analysis, and electroneurography. In four of them, the therapeutic approach included the administration of intravenous immunoglobulin (0.4 g/kg for 5 days), which resulted in the improvement of neurological symptoms. Clinical neurophysiology revealed the presence of conduction block, absence of F waves, and in two cases a significant decrease in amplitude of compound motor action potential compound muscle action potential (cMAP). Four patients presented a mild facial nerve involvement limited to the muscles of the lower face, with sparing of the forehead muscles associated to ageusia. In one patient, taste assessment showed right‐sided ageusia of the tongue, ipsilateral to the mild facial palsy. In three patients we observed albuminocytological dissociation in the cerebrospinal fluid, and notably, we found an increase of inflammatory mediators such as the interleukin‐8. Peripheral nervous system involvement after infection with COVID‐19 is possible and may include several signs that may be successfully treated with immunoglobulin therapy. Highlights: Neurological symptoms may be common in COVID‐19 patientsNeurophysiological assessment is fundamental for a correct diagnosisPeripheral nervous system involvement is possibile in people with COVID‐19In these patients, intravenous immunoglobulin administration is a safe and efficient therapy [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

21. Cognitive deficit in post-acute COVID-19: an opportunity for EEG evaluation?

Author

Giovanni Furlanis, Alex Buoite Stella, Francesco Biaduzzini, Giulia Bellavita, Nicolò Arjuna Frezza, Sasha Olivo, Alina Menichelli, Alberta Lunardelli, Miloš Ajčević, Paolo Manganotti, Furlanis, Giovanni, Buoite Stella, Alex, Biaduzzini, Francesco, Bellavita, Giulia, Frezza, Nicolò Arjuna, Olivo, Sasha, Menichelli, Alina, Lunardelli, Alberta, Ajcevic, M, and Manganotti, Paolo

Subjects
Psychiatry and Mental health, Cognitive impairment, Post-COVID-19, COVID-19, EEG, Neurology (clinical), Dermatology, General Medicine
Abstract

Background and purpose: Among the most common post-COVID symptoms, many patients experienced subjective cognitive deficit, commonly named "brain fog," that might be present also in those individuals without severe acute COVID-19 respiratory involvement. Some studies have investigated some of the mechanisms that might be associated with the brain fog with objective techniques including transcranial magnetic stimulation and neuroimaging. Methods: The aim of this study was to investigate the presence of electroencephalographic (EEG) alterations in people with post-COVID self-reported cognitive deficit. Results: Out of the 90 patients attending the post-COVID neurology ambulatory service, twenty patients presenting brain fog at least 4 weeks after acute non-severe COVID-19 infection, and without previous history of epilepsy, were investigated with 19-channel EEG, Montreal Cognitive Assessment (MoCA), and magnetic resonance imaging (MRI). EEG was found altered in 65% of the sample, among which 69% presented a slowing activity and 31% were characterized by epileptic discharges principally in the frontal areas. None of the patients showed DWI MRI lesions. Conclusions: These findings highlight the usefulness of EEG analysis to objectively describe possible neurophysiological abnormalities in post-COVID patients presenting subjective cognitive deficit.

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results